PCRX News and Press, Pacira BioSciences Inc.

2024-07-17 10:40:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Small cap stocks are e...

-- Proposed Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment System Rule extends separate payment from ambulatory surgical centers to include the hospital outpatient environment – -- Rule implements the NOPAIN Act, signed into law as part of the Cons...

2024-07-03 14:32:43 ET More on Pacira BioSciences Pacira down 25% as FDA approves generic version of Exparel Pacira BioSciences announces pricing of convertible senior notes due 2029 Pacira BioSciences, Inc. 2024 Q1 - Results - Earnings Call Presentation Paci...

A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 86.1% to $0.514 on volume of 587,366,807 shares NVIDIA Corporation (NVDA) fell 1.3% to $122.67 on volume of 214,038,378 shares Tesla Inc. (TSLA) rose 10.2% to $231.26 on volume of 201,850,947 ...

2024-07-02 14:00:06 ET Oren Livnat from H.C. Wainwright issued a price target of $57.00 for PCRX on 2024-07-02 12:36:00. The adjusted price target was set to $57.00. At the time of the announcement, PCRX was trading at $21.91. The overall price target consensus is at $48...

2024-07-02 10:06:34 ET More on Pacira BioSciences Pacira BioSciences announces pricing of convertible senior notes due 2029 Pacira Biosciences announces proposed offering of $250M aggregate principal amount of convertible senior notes Pacira BioSciences, Inc. 2024 Q1...

A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...

2024-06-23 19:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-13 14:15:06 ET Jefferies analyst issues BUY recommendation for PCRX on June 13, 2024 11:57AM ET. The previous analyst recommendation was Buy. PCRX was trading at $28.5 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analys...

2024-06-13 14:00:08 ET Glen Santangelo from Jefferies issued a price target of $36.00 for PCRX on 2024-06-13 11:57:00. The adjusted price target was set to $36.00. At the time of the announcement, PCRX was trading at $28.5. The overall price target consensus is at $52.33...